Caricamento...
Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development
Despite 50 years of extensive research, no definite drug is currently available to treat acute respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of treatment. To improve drug development for ARDS, researchers need to deeply analyze the “omics” approaches, reevalu...
Salvato in:
| Pubblicato in: | Clin Pharmacol Ther |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7162218/ https://ncbi.nlm.nih.gov/pubmed/29484641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1034 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|